TheWell Bioscience’s Post

💡 𝗦𝘁𝗮𝗿𝘁 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗲𝗻𝗱 𝗶𝗻 𝗺𝗶𝗻𝗱. 🚀 Don't let animal-based ECM limit your cell culture research progress. The xeno-free VitroGel® hydrogel helps translate your cell culture assays toward advanced biomedicine. ✨ One of the many advantages of VitroGel® over animal-based ECM is its stability at room temperature. VitroGel® remains liquid at room temperature, and its hydrogel polymerization is independent of temperature and does not require a cross-linking agent. ✅ Stable at room temperature. No unexpected gelation due to temperature fluctuation. ✅ No cross-linking reagent required. ✅ Simple, fast, and easy to use. 👉 Discover how gelation works in VitroGel®: https://lnkd.in/gGrAmV8v 👉 Try the VitroGel® Starter Kit today! https://lnkd.in/g-b7s-t2 --------------------------------------------------------------------------------- For orders outside the US, here are a few of our distributors: Tebubio, BioCat GmbH (part of AddLife), Dakewe Biotech Co., Genomax Technologies, Bio-Science Kft./Ltd. - Hungary, Immuno Diagnostic Oy, REGEMAT 3D, Sciencewerke Pte Ltd, SVEN BioLabs s.r.o., 300K Solutions, LAB-A-PORTER, The Biotech Company For more distributors: https://lnkd.in/g5jrfrVM #3DCellCulture #biotech #biotechnology #cellculture #organoid #stemcells #matrigel #cancerresearch #celltherapy #vitrogel #invitro #oncology #invivo #tissueengineering #regenerativemedicine #personalizedmedicine #precisionmedicine #cellbiology #lifescience #molecularbiology

3D Cell Culture Market Worth $2.5 Billion Download PDF Brochure: https://lnkd.in/dVxRiXx5 The global 3D cell culture market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028. Key drivers High focus on developing alternatives to animal testing Greater adoption of personalized medicine globally for multiple diseases Increased government support and funding for 3D cell culture Increased industry-academia collaboration on 3D cell culture and research 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Avantor Inc. (US), and others. 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Cell Microsystems      3D Biomatrix  Hamilton Company      TheWell Bioscience      Visikol    Nanomedicine Research Group, ICTMumbai      UPM Biomedicals     4Dcell Cherry Biotech       Qureator CelVivo Qkine  Biogelx  PeptiGel AIM Biotech   Metatissue   Lena Biosciences   Copner Biotech Ltd      PELOBiotech GmbH      KosmodeHealth Singapore      Viscofan BioEngineering      Cyprio  Biopta Zetamatrix   Luxendo Bioengineering & Organoids Technology platform      CELLEC Biotek AG Lucero Bio Revatis Biomimetic Solutions      mo:re      Nano3D Biosciences      CanCertain        MEPSGEN      Synthecon, Incorporated     

𝐇𝐮𝐦𝐚𝐧 𝐎𝐫𝐠𝐚𝐧𝐨𝐢𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞! 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dNvA4jW7 𝑻𝒉𝒆 𝒉𝒖𝒎𝒂𝒏 𝒐𝒓𝒈𝒂𝒏𝒐𝒊𝒅𝒔 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒗𝒂𝒍𝒖𝒆𝒅 𝒂𝒕 𝑼𝑺𝑫 1.19 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2024 𝒂𝒏𝒅 𝒘𝒊𝒍𝒍 𝒓𝒆𝒂𝒄𝒉 𝑼𝑺𝑫 2.33 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2029 𝒂𝒕 𝒂 𝑪𝑨𝑮𝑹 𝒐𝒇 14.4% The rapidly growing number of #clinicaltrials drives the human organoids market on an extensive scale by generating an increased demand for innovative models that mimic human physiology. These models let researchers test the efficacy and toxicity of drugs on patient-specific models, thereby providing more precise treatments. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Thermo Fisher Scientific Corning Incorporated Merck KGaA, Darmstadt, Germany BioIVT HUB Organoids BICO BeCytes Biotechnologies InSphero GBA Group Kirkstall Ltd. MIMETAS Neuromics PRIMACYT Cell Culture Technology GmbH STEMCELL Technologies ACROBiosystems

Biomarkers Market Size To Hit USD 93.8 Billion by 2029 Download Free Sample Report-https://lnkd.in/dmKwWDPH The size of global biomarkers market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at a CAGR of 10.2% from 2024 to 2029. Companies Working in the Market Tecan Immatics Nordic Bioscience   Medicines Discovery Catapult Ad Scientiam IXICO Oncodesign Services Quibim Universal Diagnostics S.A. Centre for Human Drug Research Olink Proteomics TRON-Mainz Takis Beats Medical Citoxlab, a Charles River Company BioSerenity Fios Genomics Idoven Rockley Photonics  Radiomics.bio Pelago Bioscience AB OncoDNA Bioneer A/S     iLoF Indivi BioArctic Optics11 Life Brainomix EATRIS Amadix Fujirebio Europe PrecisionLife Aiforia Technologies Pear Bio Anaxomics Biotech S.L. Fundacion MEDINA Definiens, The Tissue Phenomics Company Microbiotica     Engitix Therapeutics

CRISPR Market to Grow $7.1 Billion by 2028 Download Sample PDF Report-https://lnkd.in/ddZq79mv The global CRISPR market in terms of revenue was estimated to be worth $3.4 billion in 2023 and is poised to reach $7.1 billion by 2028, growing at a CAGR of 15.6% from 2023 to 2028. Companies Working in the Market KromaTiD™ Inc.   EditCo Bio Vittoria Biotherapeutics, Inc.     Bio Bureau Biotechnology    Mary Lyon Centre at MRC Harwell  FOLIUM Science    Amber Bio Okomera  Recombinetics   InVivo Biosystems  Algen Biotechnologies   Hello Bio Max Planck Unit for the Science of Pathogens      Community of Biotechnology   Caszyme Function  Integra Therapeutics    HuidaGene Therapeutics       iotaSciences Microsynth AG Biocentis Iribov VoltSafe Inc. Alia Therapeutics Ligandal Stem Genomics    Ancilia Biosciences Foundation for Advanced Education in the Sciences (FAES)    Xap Therapeutics bit.bio discovery National Institute for Genomics and Advanced Biotechnology (NIGAB)     

Acid-degradable Anionic Lipid (ADA) DC Chemicals developed a novel Acid-degradable Anionic Lipid in stock for LNP research. Acid-degradable Anionic Lipid (ADA) composed of anionic lipid is synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improves the performance of LNP-mRNA complexes in vitro and in vivo. https://lnkd.in/gXtdzHv8 References: 1 Acid-degradable lipid nanoparticles enhance the delivery of mRNA-Sheng Zhao, Aijun Wang, Niren Murthy, Nat Nanotechnol 2024 Aug 23. 2 Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein Kai Chen, Hesong Han, Sheng Zhao, Bryant Xu, Boyan Yin, Atip Lawanprasert, Marena Trinidad, Benjamin W. Burgstone, Niren Murthy & Jennifer A. Doudna ---Nature Biotechnology (2024)

𝐋𝐢𝐪𝐮𝐢𝐝 𝐍𝐢𝐭𝐫𝐨𝐠𝐞𝐧 𝐂𝐫𝐲𝐨𝐩𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐂𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 The increasing demand for advanced preservation techniques in the healthcare and biotechnology sectors, particularly for stem cell storage, fertility preservation, and gene therapy, is driving the growth of the liquid nitrogen cryopreservation container market. These containers are essential for maintaining biological samples at ultra-low temperatures, ensuring their viability for long-term use. Rising investments in biobanking, along with technological advancements, are further propelling market expansion. 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨@https://lnkd.in/ddSXqTse 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 Thermon, Air Products, Helmer Scientific, Thermon, Boston Scientific, Platinum Pharmaceuticals (Pvt.) Ltd., ASKION Biobanking, Entegris, LMK Thermosafe Ltd, CELSIUS, Merck Group, Zhejiang Huahai Pharmaceutical Co., Ltd, STERIS, NuAire Lab Equipment, Universitätsklinikum Hamburg Eppendorf, BIOCODEX, CELSIUS, Boston Scientific, Thermo Fisher Scientific, Beckman Coulter Diagnostics, Thermolab India. #Cryopreservation #Biotech #LiquidNitrogen #MarketGrowth

𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐋𝐢𝐯𝐞 𝐂𝐞𝐥𝐥 𝐄𝐧𝐜𝐚𝐩𝐬𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/d4keHs6J The Live Cell Encapsulation Market is poised for tremendous growth, with a projected valuation of USD 309.95 million by the year 2032, showcasing a compelling CAGR of 4.01%. This impressive trajectory can be attributed to the increasing demand for innovative solutions in cell therapy and regenerative medicine. Live cell encapsulation technology offers a promising avenue for the delivery of therapeutic cells, protecting them from immune rejection and enhancing their efficacy. Additionally, advancements in biomaterials and biocompatible encapsulation techniques are driving the market forward, providing opportunities for personalized medicine and treatment of chronic diseases. The growing investments in research and development further underscore the potential for transformative breakthroughs in healthcare applications. As we look towards the future, the Live Cell Encapsulation Market stands as a key player in shaping the landscape of regenerative therapies and precision medicine. 𝗠𝗮𝗷𝗼𝗿 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱 𝗶𝗻 𝗥𝗲𝗽𝗼𝗿𝘁: Balchem Corporation ViaCyte Evonik InSphero Neurotech Pharmaceuticals, Inc. Beta-o2 Technologies Ltd. Kadimastem Ltd. TheraCyte, Inc. Austrianova Merck Life Science Sphere Fluidics Limited BIO INX Isogen Arsenal Biosciences, Inc. #LiveCellEncapsulation #CellTherapy #Biotechnology #RegenerativeMedicine #CellularMedicine #EncapsulationTechnology #StemCellResearch #CellularTherapies #Biomaterials #BiomedicalEngineering #CellEngineering #BalchemCorporation #ViaCyte #Evonik #InSphero #NeurotechPharmaceuticals #BetaO2Technologies #Kadimastem #TheraCyte #Austrianova #MerckLifeScience #SphereFluidics #BIOINX #Isogen #ArsenalBiosciences

Biomarkers Market Size To Hit USD 93.8 Billion by 2029 Download Free Sample Report-https://lnkd.in/dmKwWDPH The size of global biomarkers market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at a CAGR of 10.2% from 2024 to 2029. Companies Working in the Market NANOVERY CBmed GmbH Proteome Sciences plc HistologiX Cavidi Dawako Medtech BIOMED-UHasselt OmicScouts Dxcover A4P, A LabConnect Company Resolve Stroke Wellabe Alivion ABCDx SA   RumeXperts ProAxsis Cleara Biotech B.V. York Bioanalytical Solutions   AIT Bioscience ET Healthcare Envol Biomedical LinusBio ARBOR ASSAYS Interleukin Genetics MedQIA, LLC Decode Health Pangea Laboratory BioFluidica, Inc. WaferGen Biosystems Ethos Biosciences Neurosteer Vigilant Biosciences, Inc.  Hyperion Biotechnology, Inc. MiraDX, Inc.

Al in Biotechnology Market: Growth, Size, Share, and Trends Download Free Sample Report-https://lnkd.in/dcHkHyN9 The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. The North America AI in biotechnology market is expected to be worth USD 3.22 billion by 2029, growing at CAGR of 18.5% during the forecast period. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 NVIDIA Illumina Exscientia Schrödinger Recursion SOPHiA GENETICS Predictive Oncology Deep Genomics Data4Cure, Inc. GENOOX (US) BenevolentAI DNAnexus Tempus AI NuMedii XtalPi Inc. Lifebit Biotech (England) BPGbio, Inc. Valo Health (US) VeriSIM Life (US) iktos (France) Insilico Medicine Eurofins Discovery Logica Aganitha